Fibrosis in immune control of mammary-tumor growth

Int J Cancer. 1992 May 8;51(2):325-8. doi: 10.1002/ijc.2910510225.

Abstract

In malignancies, an interruption of growth (dormancy) is sometimes observed. In the immunogenic mammary carcinoma MC2, dormancy followed by regression after a period of growth was observed in 18% of s.c. implants in normal mice. Dormant implants removed for histologic examination were invariably found to be completely surrounded by a highly fibrous stroma. Fibrosis was enhanced in immunized mice, and reduced in immuno-deficient mice. Surgical disruption of the fibrous capsule around dormant tumors early (19 +/- 3 days) in the immune response led more frequently to resumed growth, while later (32 +/- 3 days) disruption of the capsule led more frequently to complete regressions. This showed that fibrous capsules that could destroy tumors could also shield them against well-developed systemic immune mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Division
  • Female
  • Fibrosis / immunology
  • Fibrosis / pathology
  • Mammary Neoplasms, Animal / immunology
  • Mammary Neoplasms, Animal / pathology*
  • Mice
  • Mice, Inbred C3H
  • Mice, Nude
  • Mitotic Index
  • Neoplasm Regression, Spontaneous / immunology
  • Neoplasm Regression, Spontaneous / pathology*
  • Neoplasm Transplantation
  • Transplantation Immunology